Trial Details
COMPLETEDBasic Information
| Clinical ID | c718 |
|---|---|
| Identifier | NCT05706038 |
| Trial Title | Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Rheumatic Disorder |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | IRCCS San Raffaele |
|---|---|
| City | Milano |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-04-27 |
|---|---|
| Primary Completion Date | 2022-10-31 |
| Completion Date | 2022-10-31 |